The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 12, 2016
Filed:
Jan. 09, 2014
Applicant:
Santen Pharmaceutical Co., Ltd., Osaka, JP;
Inventors:
Sreenivasu Mudumba, Union City, CA (US);
Philippe J M Dor, Cupertino, CA (US);
Thierry Nivaggioli, Atherton, CA (US);
David A. Weber, Danville, CA (US);
Sidiq Farooq, Newark, CA (US);
Assignee:
SANTEN PHARMACEUTICAL CO., LTD., Osaka, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/48 (2006.01); A61K 9/19 (2006.01); A61K 31/45 (2006.01); A61K 31/44 (2006.01); A61K 31/47 (2006.01); A61K 47/10 (2006.01); A61K 47/12 (2006.01); A61K 47/44 (2006.01); A61K 31/436 (2006.01); A61K 9/00 (2006.01); A61K 31/045 (2006.01); A61K 31/4745 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0048 (2013.01); A61K 9/0019 (2013.01); A61K 31/045 (2013.01); A61K 31/436 (2013.01); A61K 31/44 (2013.01); A61K 31/4745 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/44 (2013.01);
Abstract
Described herein are liquid rapamycin formulations. Described herein are methods of treating or preventing diseases or conditions, such as choroidal neovascularization, wet AMD and dry AMD, and preventing transition of dry AMD to wet AMD, using the liquid rapamycin formulations described herein.